XLO short interest
Xilio Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 410,050 |
|---|---|
| Change vs prior report | -2,913 (-0.7%) |
| Change over six months | +124.7% |
| Days to cover | 44.52 (sector: 3.78) |
| Average daily volume | 9,210 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
XLO short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 410,050 | -0.7% | 44.52 | 9,210 |
| 2026-09-15 | 412,963 | -1.3% | 37.36 | 11,055 |
| 2026-08-31 | 418,277 | -0.9% | 39.07 | 10,705 |
| 2026-08-14 | 421,921 | -0.9% | 31.63 | 13,340 |
| 2026-07-31 | 425,882 | +58.8% | 12.28 | 34,680 |
| 2026-07-15 | 268,180 | +53.6% | 4.52 | 59,349 |
| 2026-06-30 | 174,619 | +0.7% | 3.65 | 47,868 |
| 2026-06-15 | 173,470 | +5.0% | 7.09 | 24,458 |
| 2026-05-29 | 165,274 | -3.6% | 5.43 | 30,465 |
| 2026-05-15 | 171,370 | +5.2% | 1.80 | 95,033 |
| 2026-04-30 | 162,958 | -6.5% | 4.94 | 32,972 |
| 2026-04-15 | 174,319 | -4.5% | 5.92 | 29,431 |
| 2026-03-31 | 182,492 | -91.8% | 3.13 | 58,298 |
| 2026-03-13 | 2,231,716 | +5.6% | 4.64 | 480,808 |
| 2026-02-27 | 2,113,748 | -1.9% | 6.77 | 312,226 |
| 2026-02-13 | 2,155,562 | +0.8% | 3.58 | 602,303 |
| 2026-01-30 | 2,139,403 | +2.4% | 4.14 | 516,334 |
| 2026-01-15 | 2,088,847 | -3.7% | 5.83 | 358,062 |
| 2025-12-31 | 2,168,608 | -29.8% | 8.04 | 269,707 |
| 2025-12-15 | 3,088,368 | -53.7% | 4.19 | 737,184 |
| 2025-11-28 | 6,675,820 | -3.4% | 17.93 | 372,254 |
| 2025-11-14 | 6,913,181 | +12.3% | 5.92 | 1,166,847 |
| 2025-10-31 | 6,156,308 | +17.2% | 8.58 | 717,816 |
| 2025-10-15 | 5,251,586 | +1.7% | 12.42 | 422,788 |
| 2025-09-30 | 5,162,356 | +4.8% | 13.34 | 386,950 |
import finzdata as yf
yf.Ticker("XLO").short_interest # every report since 2017
yf.Client().short_interest(["XLO"], start="2018-01-01")Healthcare short interest · XLO price history · Who owns XLO · All short interest